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Abstract  
Arising multidrug resistance to available antibiotics is a problem of deep scientific and research concern. One organism 
with increasing antibiotics resistance is Klebsiella spp. that had cause several outbreaks in different locations. This study 
was undertaken to investigate the antibiogram and susceptibility of Klebsiella spp. isolated from clinical samples in health 
care centers. The study was conducted in Auchi Township in Etsako West Local Government Area, Edo State, Nigeria. 
Following standard procedures samples were collected and Klebsiella spp. identified using standard microbiology 
techniques. Antibiotic susceptibility testing was carried out using standard methods. 109 samples were collected and 
comprised urine (44), wound (20), high vagina swabs (17), urethral (3), sputum (9), semen (6), stool (5), endo-cervical 
swab (2), throat (1) and ear (1). 10 (9.17%) samples were positive to Klebsiella organism with urine consisting 50.0% and 
10.0% each from sputum, stool, wound, ear and high vaginal swabs. Klebsiella isolates were completely resistance to 
penicillin, Amoxiclav and Chloramphenic. Amoxicillin, Floxapen, Metronidazole, Ampicillin, Cotrimoxazole, Nalidixic 
acid, Streptomycin, Tetracycline, Cephalexin, Genticin, Tobramycin, Nitrofurantoin, Ciprofloxacine and Cefuroxime have 
less than 50% potency. On the other hand, Ofloxacine, Cefotaxime, Ampisulbactam and Perflacine were 50% and above 
susceptible. Klesiella spp. isolated from stool sample was more multi-drug resistance (87.75%) followed by those from 
wound (77.55%), sputum (73.47%), high vaginal swab (69.39%), urine (65.30%) and lastly ear sample (48.98). Based on 
our findings, Klebsiella spp. in the study area is multidrug-resistance thus suggesting antibiotic analysis prior to treatment. 
American Journal of Current Microbiology 
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Introduction 
Klebsiella species is a Gram negative opportunistic pathogen and well known to clinicians as a cause of 
community acquired bacterial pneumonia, occurring particularly in chronic alcoholics, urinary tract 
infections, wound infections, blood infections and infections in the intensive care unit [1, 2]. The genus 
Klebsiella comprises of five species, Klebsiella pneumoniae, Klebsiella oxytoca, Klebsiella planticola, 
Klebsiella terrigena and Klebsiella ornithinolytica [3]. Of all five species, Klebsiella pneumoniae is the 
most common hospital-acquired pathogen causing lung infections, wound infections, meningitis, abscesses, 
urinary tract infections and diarrhea [4] and has been reported to cause outbreak of sepsis and death of 
newborns in the intensive care unit in Brazil [5], United Kingdom [6] and France [7]. It was therefore 
identified as an important common pathogen causing nosocomial pneumonia (7 to 14% of all cases), 
septicaemia (4 to 15% of all cases), wound infections (2 to 4% of all cases) and neonatal septicaemia (3 to 
30% of all cases) [8]. In addition, it is said to be a normal flora of the intestine and are found in respiratory 
tract of humans and animals [2]. While cockroaches were suggested to play the role of vectors of this 
hospital-acquired pathogen, they have also been found in aquatic environments and industrial waste waters 
[9], plant products and fresh vegetables [10]. 
 
As an opportunistic pathogen, Klebsiella spp. primarily attacked immune-compromised individuals, who 
are hospitalized and suffer from severe underlying diseases such as diabetes mellitus or chronic pulmonary 
obstruction, chronic cardiac, renal and neoplastic disease [2, 11-12]. Worrisome, reports suggest that 
Klebsiella is emerging worldwide and has become a serious threat to human health by causing endemic and 
epidemic infections [13]. Although progress has been made in approaches to infection treatments and 
antibiotics production, bacteria have developed resistant against available antibiotics and have made the 
treatment of infectious diseases even more difficult [14]. 
 
For example, beta-lactam antibiotics or alternatively with aminoglycosides or floroquinolones are often 
the drugs of choice for infections caused by Klebsiella spp. however, resistant of this organism to these 
antibiotics have been reported [15-17]. Development of antibiotic resistance in Klebsiella spp. and the 
production of multidrug-resistant strains have cause infections by these strains to become challenging [18]. 
In 1980, the resistant of Klebsiella strains to the cephalosporins such as oxyimino beta-lactams (ceftriaxone, 
ceftazidime, cefotaxime) was reported and recorded for the first time and since then Klebsiella bacteria 
were ever more resistant to antibiotics [19].  
 
In fact, multidrug resistant Klebsiella pneumonia has been reported [20] and was suggested to be due to 
plasmid encoding extended-spectrum β-lactamases (ESBLs). At the level of a wider geographic scale, the 
incidence of extended-spectrum β-lactamases (ESBL) producing organisms was reported to be difficult to 
resolve due to difficulty in detecting ESBL production and inconsistencies in reporting [21]. Recent several 
studies have documented significant increase in the incidents of ESBL-related infections and it’s observed 
throughout the globe [22-28]. Despite this reports of multiple antibiotics resistance and variation between 
geographical locations, few studies have been conducted in Nigeria with a few in Edo State and non in 
Etsako West Local Government Area of Edo State. This study therefore was embarked on to investigate the 
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antibiogram and susceptibility of Klebsiella spp. isolated from different clinical specimen in a Medical 
Center, a laboratory and a general hospital in Etsako West Local Government Area of Edo State. 
Materials and Methods 
Study area: This study was carried out in Auchi township and environ (7º04'N, 6º16'E) in Edo State, 
Nigeria between 15th of January to 15th of April 2015. The area is the head-quarters of the Etsako West 
Local Government Area and a host to a tertiary institution (Auchi Polytechnic, Auchi), several secondary 
and primary school, several clinic, laboratories and government owned health care facilities. 
 
Sampling: A total of 109 clinical specimens which includes urine, blood, stools and swabs (wound, throat, 
and ear swabs) were collected from randomly selected clinics consisting of a private clinic (Fate Medical 
Center), a government owned health facility (General hospital, Auchi) and a medical laboratory 
(Medi-view laboratory) in Auchi Township. Specimens were transported to the diagnostic laboratory of 
Fate Foundation Hospital and stored at 4oC refrigerator before culturing, isolation and provisional 
identification. Analysis was done within 24hrs of collection. Isolates were placed on Nutrient agar slopes 
and stored in the refrigerator. Periodically, isolates were transferred to the microbiology laboratory at 
Ambrose Alli University Ekpoma for confirmatory identification. 
 
Identification of Isolates: Isolates were cultured on MacConkey agar and nutrient agar under aseptic 
conditions [29-31]. The MacConkey agar and Nutrient agar plates were incubated at 37oC. After overnight 
incubation, growths of suspected organisms were identified by their colonial morphology and biochemical 
characteristics [32]. These tests include the following; 
 
1. Gram Stain: Discrete colonies of the test organisms were obtained aseptically with sterile wire 
loop and emulsified in drop of normal saline on a clean sterile glass slide. The smear was air dried 
and then heat fixed by passing it slightly through a Bunsen burner flame. Then the fixed smear was 
covered with crystal violet stain on a staining rack for 30 seconds, and then washed off with 
distilled water. The smear was then flooded with luguol’s iodine for one minute, and then rinsed 
with distilled water. The smear was decolourized with acetone for 10 seconds and was 
immediately washed off with distilled water. The smear was counter stained with neutral red for 
one minute, washed off and then allow to air dry. A drop of immersion oil was placed on the stain 
potion of the slide and it was viewed under x100 objective lens. All Gram negative organisms were 
pinkish or pale to dark red in colour, which is as a result of the secondary dye while gram positive 
organisms were usually purple in colour which was the colour of the primary dye. 
2. Motility Testing: A molded plasticine ring was set on a clean slide. A loopful of an overnight broth 
culture of the test organism was taken unto a cover-slip, and the slide was inverted on the 
cover-slip making sure that the culture drop was within the plasticine ring but without touching the 
ring. This was inverted and examined under the x10 and x40 objectives. 
3. Catalase Test: Catalase test was carried out by placing a drop of hydrogen peroxide on a clean 
grease free glass slide. A colony of the test organism was taken with a sterile platinum wire loop, 
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and emulsified in the hydrogen peroxide on the slide. The production of gas bubbles which 
indicated positive result was then observed. 
4. Oxidase Test: A piece of filter paper was placed on a clean Petri-dish and two drops of freshly 
prepared oxidase reagent was added. Then a colony of the test organism was smeared on the 
oxidase reagent soaked filter paper. Development of a deep purple colour within 10 seconds 
indicated positive result. 
5. Urease Test: This test the ability of certain organisms to produce the enzyme urease which 
decomposes urea into alkaline, ammonia and carbon (iv) oxide. The test organism was inoculated 
heavily in bijou bottle containing 3ml of sterile Christensen’s modified urea broth. It was 
incubated at 37oC for 12 hours. A pink colour in the medium indicated a positive result. 
6. Coagulase Test: This test is used to differentiate Staphylococcus aureus which produces the 
enzyme coagulase, from S. epidermidis and S. saprophyticus which do not produce coagulase. 
Coagulase causes plasma to clot by converting fibrinogen to fibrin. Two types of coagulase are 
produced by most strains of S. aureus. Free coagulase converts fibrinogen to fibrin by activating a 
coagulase reacting factor present in plasma and this is detected by the appearance of a fibrin clot in 
the tube test while bound coagulase (clumping factor) converts fibrinogen directly to fibrin 
without requiring a coagulase –reacting factor. It can be detected by the clumping of bacterial cells 
in the rapid slide test. A slide coagulase test is run with a control to rule out auto agglutination. 
Two drops of physiological saline are put onto a slide labeled with test (T) and control (C), the two 
saline drops are emulsified with the test organism using a wire loop. A drop of plasma is placed on 
the inoculated saline drop corresponding to test, and mixed well, then the slide is rocked gently for 
about ten seconds and observes for clumping. No clumping is an indication of a negative result. If 
slide coagulase is negative this is followed by a tube test for further confirmation. The tube test 
uses rabbit plasma that has been inoculated with Staphylococcal colony (i.e. Gram positive cocci 
which are catalase positive). The tube is incubated at 37oC for 1 hour. If negative, then incubation 
is continued up to 18 hours. If positive, the plasma will coagulate. 
7. Indole Test: This test is used to demonstrate the ability of certain bacteria to decompose the amino 
acid tryptophan to indole which accumulates in the medium; the organism is inoculated into 
peptone water and incubated overnight at 37oC. The presence or formation of indole is tested by 
adding a few drops of kovac’s reagent (0.2-0.3). The test tube is well shaken and allowed to stand, 
the formation of a dark red colouration indicates a positive result and no colour change indicates a 
negative result. 
8. Citrate Test: Slant of medium containing citrate and ammonium salt was prepared in bijoux bottles 
and stored at 4oC in the refrigerator, with the use of a sterile wire; the slant was streaked with a 
saline suspension of the test organism and then stabbed into the medium followed by incubation at 
35OC for 48 hours. A bright colour indicated positive result. 
9. Indole Test: Bijou bottles containing 3ml of sterile peptone water was inoculated with test 
organism, and then incubated at 37OC for 48 hours. Thereafter, 0.5ml Kovac’s reagent was added 
and shaked gently. Positive result was indicated by the formation of red colour in the surface layer 
within 10 minutes. 
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Antibiotic susceptibility testing: Prepared antibiotic discs were used as follows; A 1/100 dilution of an 
overnight nutrient broth culture of each test organism was poured on the surface of nutrient agar plate that 
was notched round. The excess broth was discarded into a disinfectant jar. The plates were left to stand on 
the bench top for 30 minutes. After 30 minutes, the antibiotic discs were placed on the surface of the 
inoculated agar medium. The plates were incubated at 37oC for 24 hours after which the zones of inhibition 
were observed and recorded. Zones of up to 13 mm diameter or over were recorded as sensitive while those 
less than 13 mm were regarded as resistance [29]. 
 
Preparation of antibiotic susceptibility discs: In cases where the commercially prepared antibiotic discs 
were not available, the discs were personally prepared as follows: Whattman No.1 filter paper discs with 
diameter of 6 mm were punched out with a paper puncher. One hundred of the discs were counted into 
bijoux bottles. The bottles and the discs were sterilized in a hot air over at 1400C for 2 hrs. The bottle and its 
contents were allowed to cool to room temperature. The discs were then aseptically inoculated with I ml of 
the pre-prepared antibiotic solution. The bottles’ caps were partly screwed down and allowed to dry 
overnight in a 370 C incubator [29]. 
 
Antibiogram typing: This was done by dividing the 21 antibiotics into seven different groups of 3 
antibiotics each according to their mode of action, similarities and usage [33]; antibiotics were arranged in 
ascending order of their molecular weight or their generations in each group of 3 antibiotics viz; 
Group 1: Ampicillin, Amoxicillin and Cloxacillin; These are bacteria cell wall synthesis inhibitors. They 
impair cell wall synthesis by preventing cross-binding of the peptidoglycan polymers necessary for cell 
wall formation and by binding the penicillin-binding proteins (PBPs) (carboxypeptidases, endopeptidases, 
and transpeptidases) that participate in cell wall synthesis. 
 
Group 2: Flucloxacillin, Amoxyclav and Ampisulbactam; These are broad-spectrum penicillin with a 
fluorinated side chain in the first and attached clavulanic acid in the other two 
 
Group 3: Genticin, Tobramycin and Streptomycin; These are Aminoglycocides- broad spectrum, protein 
synthesis inhibitors, active against aerobes only. 
 
Group 4: Chloramphenicol, Tetracycline and Cotrimoxazol; Septrin is a folic acid inhibitor 
while the other two are protein synthesis inhibitors. Here, they represent the most commonly used (abused) 
antimicrobials in the community. 
 
Group 5: Metronidazole, Nitrofurantoin and Nalidixic acid; Metronidazole is anti-protozoan but is also 
active against anaerobic and facultatively anaerobic bacteria; Nitrofurantoin is active against Gram-positive 
and Gram-negative bacteria and is mostly used as urinary antiseptic while antimicrobial activity of early 
quinolones (the first generation quinolones) such as Nalidixic acid, are excellent against aerobic 
Gram-negative bacteria. 
 
Group 6: Ofloxacin, Ciproxin and Peflacine; Quinolones act by inhibiting the action of topoisomerases II 
(DNA gyrase) and topoisomerase IV. For Gram-negative bacteria the prime target of quinolones is the 
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DNA gyrase, whereas in the Gram-positives it is the topoisomerase IV. These three quinolones act by 
inhibiting the DNA gyrase. 
 
Group 7: Cephalexine, Cefotaxime and Cefuroxime; Cephalexin is an oral penicillin substitute that is active 
mainly against Gram-positive organisms while the latter two are broad spectrum and highly active against 
Gram-positive and Gram- negative organisms. These drugs are highly expensive, and they are usually not 
abused. 
Ajumali
,
s method of pneumonic coding [34]: This in an adaptation of Ajumali’s method of pneumonic 
coding [33,34]. Sensitive result was scored as (+) while resistance was recorded as (-). The three antibiotics 
in each group were given numerical values of 1, 2, and 4. A perfect sensitivity to the three antibiotics will 
give a summation of 1+2 +4 = 7. On the other hand, complete resistance to the three antibiotics will give a 
summation of 0+0 +0 is =0. Other values are obtained by adding up these numerical values; in which case 
an isolate can receive a score of 0-7 in each triplet segment. Combining the seven-triplet segments together 
then gives a seven-digit numerical value as the antibiogram type.  
 
Materials/Instrumentation and Techniques: The equipment  used in this study include the following; 
hot air oven, incubator, Aluminium foil paper, Petri dishes, measuring cylinder, Bijou bottles, Cotton wool, 
test tubes, sterile hand gloves, Masking tape, glass slides, Nutrient agar, Mueller Hinton agar, Normal 
physiological saline, acridine orange/sodium dodecyl sulphate. Media were prepared according to the 
manufacturer’s instruction. Cultural characteristics were observed using standard microbiological 
techniques. Pure cultures were isolated, Gram stained, followed by biochemical tests to identify the isolates. 
All glass wares were washed with detergent, rinsed in distilled water and sterilized at 100oC in the hot air 
oven for 1 hour before use while wire loops were sterilized by passing them through a Bunsen burner flame 
until it was red hot before use. 
Results and Discussion 
Analysis of the results showed that the collected clinical specimens comprised of 55 females (50.5%) and 
54 males (49.4%) samples. The number of clinical specimens obtained were 44 urine samples, 20 wound 
samples, 17 high vagina swabs, 3 urethral swabs, 9 sputum samples, 6 semen samples, 5 stool samples, 2 
endo-cervical swab and 1 each of throat and ear swabs (see Table 1). Of the 109 clinical samples examined, 
10 were associated with Klebsiella organisms. This gives a prevalence rate of 9.17%. This is high compared 
to the 5.11% (100 Klebsiella isolates from 1957 clinical samples) reported for a rural teaching hospital in 
India [35] or the 2.4% (24 Klebsiella isolates from 1000 clinical samples) reported for Federal Teaching 
Hospital Abakaliki, Ebonyi State [36] or the 2.99 reported for the National hospital Abuja, Central Nigeria 
[37]. The observed prevalence of Klebsiella in our study is low compared to the 17.3% (Klebsiella 
pneumoniae) reported for a tertiary health care facility in Yola, Northern Nigeria [38],  38.5% (150 
Klebsiella pneumoniae isolates from 390 clinical samples) reported for University of Nigeria Teaching 
Hospital, Ituku Ozalla in Enugu capital city in South-Eastern Nigeria [39]. Our finding therefore suggests 
that Klebsiella spp is prevalent in the clinical samples and by implication in clinics within Auchi Township 
area of Estako West Local Government Area of Edo State. 
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Specifically, of the 10 Klebsiella organisms isolated, 5 (50.0% of K. spp. isolates) were from urine sample, 
1 each (10.0% of K. spp. isolates) was from sputum, stool, ear swab, wound and high vaginal swab samples 
(see Table 1). The observed higher representation of Klebsiella infestation in urine sample (50.0%) in our 
study is similar to the finding by Ali Abdel Rahim and Ali Mohamed [40], where isolation rate of Klebsiella 
spp was said to be more from pus, followed by urine, sputum and catheter tip. Romanus and Egwu [39] have 
also reported similar distribution of Klebsiella infestation. Our finding therefore indicates that Klebsiella 
infestation is more likely related to urinary tract infections. 
 
Table 1  Distribution of Klebsiella bacteria isolates from specimen according to clinical samples 
 
KEY: HVS = High vagina, ECS = Endo-cervical swab 
 
 
 
Figure 1 Comparative susceptibility and resistibility of Klebsiella spp. isolates to antibiotics (Key %R = percentage 
resistivity, %S = percentage sensitivity). 
 
 
Antibiogram typing of the isolated Klebsiella spp. (Table 2) showed that ear swab isolate was more 
sensitive (51.02%) to antibiotics.  This was followed by Klebsiella spp. isolated from urine samples 
(34.70%), high vaginal swab (30.61%), sputum (26.53%), wound (22.45%) and lastly stool sample 
(12.25%) (see Table 2). This finding disagrees with the report by Romanus and Egwu [39], who 
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observed that Klebsiella pneumoniae from wound samples were the most susceptible strains followed by 
HVS, sputum and urine. In our study, Klebsiella spp. isolated from stool sample was more multi-drug 
resistance followed by those from wound sample, sputum, high vaginal swab, urine and lastly ear sample 
(see table 3). 
 
Table 2 Antibiogram types and antibiotics sensitivity of the clinical Klebsiella spp. isolates  
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Key: Conc. = concentration of drugs per disk (µg);  + = Sensitive; - = Resistance, K1 to K5 = Klebsiella isolates from 
urine, K6 to K10 = Klebsiella isolate from sputum, stool, ear swab, wound and High vaginal swab respectively; AP = 
antibiotic potency; GCP = Antibiotic group cumulative potency; % sensitivity = [(S/49)X100]; TABS = Total 
antibiotics sensitivity. 
 
On antibiotics susceptibility (see Table 2, 3 and Figure 1), our results showed that Klebsiella spp. 
isolates were completely resistance to the antibiotic action of penicillin, Amoxiclav and Chloramphenic. 
Amoxicillin, Floxapen and Metronidazole presented 10.0% antibiotic action against Klebsiella spp. and 
these were followed by Ampicillin (20.0%), Cotrimoxazole (20.0%), Nalidixic acid (20.0%), 
Streptomycin (30.0%), Tetracycline (30.0%), Cephalexin (30.0%), Genticin (40.0%), Tobramycin 
(40.0%), Nitrofurantoin (40.0%), Ciprofloxacine (40.0%) and Cefuroxime (40.0%). Ofloxacine and 
Cefotaxime showed 50% susceptibility while Ampisulbactam showed 60% susceptibility and Perflacine 
showed 70% susceptibility (see Table 2, 3 and Figure 1). Overall, the group 1 antibiotic (Ampicillin, 
Amoxicillin) presented the least potency (10.0%) while the group 6 antibiotic (Cloxacillin Ofloxacin, 
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Ciproxin and Peflacine) presented the highest antibiotic potency to Klebsiella spp. (see table 2). The 
high resistance of Klebsiella spp. to amoxicillin antibiotic (R=90.0%) in this study is similar to the study 
by Dallal et al. [41] and Langarizadeh et al. [42] who reported 97% and 98.61% respectively.  
 
Table 3 Comparative resistivity pattern of Klebsiella spp. isolated from different clinical specimen to antibiotics 
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Ampisulbactam 40.0 100.0 0.0 0.0 0.0 100.0 60.0 40.0 
Genticin 60.0 100.0 100.0 0.0 0.0 100.0 40.0 60.0 
Streptomycin 60.0 100.0 100.0 0.0 100.0 100.0 30.0 70.0 
Tobramycin 60.0 100.0 100.0 0.0 100.0 0.0 40.0 60.0 
Tetracycline 80.0 100.0 100.0 100.0 0.0 0.0 30.0 70.0 
Chloramphenicol 100.0 100.0 100.0 100.0 100.0 100.0 0.0 100.0 
Cotrimoxazole 80.0 0.0 100.0 100.0 100.0 100.0 20.0 80.0 
Nitrofurantoin 60.0 100.0 100.0 0.0 100.0 0.0 40.0 60.0 
Metronidazole 80.0 100.0 100.0 100.0 100.0 100.0 10.0 90.0 
Nalidixic acid 80.0 0.0 100.0 100.0 100.0 100.0 20.0 80.0 
Ofloxacine 10.0 100.0 100.0 100.0 100.0 0.0 50.0 50.0 
Ciprofloxacine 60.0 100.0 100.0 0.0 100.0 0.0 40.0 60.0 
Perflacine 0.0 100.0 100.0 100.0 0.0 0.0 70.0 30.0 
Cephalexin 80.0 0.0 100.0 0.0 100.0 100.0 30.0 70.0 
Cefotaxime 60.0 100.0 0.0 0.0 100.0 0.0 50.0 50.0 
Cefuroxime 60.0 0.0 100.0 0.0 100.0 100.0 40.0 60.0 
Total Resistance 68.10 80.95 90.48 52.38 76.19 66.67 29.05 70.95 
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The antibiotics susceptibility observed in our study were in variants compared to the findings by 
Romanus and Egwu [39] who reported higher susceptibility profiles as follows; imipenem (100%), 
amikacin (100%), cefoxitin (99.4%), aztreonam (98%), ceftazidime (98%), cefotaxime (96.7%), 
amoxicillin/clavulanic acid (96%), ciprofloxacin (96%), tobramycin (93.3%), kanamycin (90%), 
cefuroxime (86.7%), gentamicin (76%), sulphamethoxazole/trimethoprim (22%), chloramphenicol (15.4%) 
and ampicillin (5%). On the other hand, Abubakar (2009) reported lower susceptibility compared to 
Romanus and Egwu [39] but higher than what was observed in our study. Specifically, Abubakar [38] 
reported susceptibility profile of Klebsiella pneumoniae to be 65.4% (augmentin), 58.5% (ofloxacin), 55.0% 
(nalidixic acid), 52.7% (erythromycin) 51.7% (nitrofurantoin), 50.5% (chloramphenicol),50.0% (colistin), 
49.0% (streptomycin),38.8% (pefloxacin and gentamycin respectively), and 42.3% (ampicillin). 
 
The variations in antibiotics susceptibility between our presence study and others studies indicate 
differences in multiple antibiotic resistance (MAR) of Klebsiella spp. In fact, nosocomial isolates are now 
reported to be now frequently resistant to numerous antibiotics. This was said to be due to acquisition of 
multidrug resistance (MDR) plasmids and Klebsiella pneumonia has been identified as one of the most 
common organisms to carry plasmid encoding extended-spectrum β-lactamases (ESBLs), and such strains 
are isolated with increasing frequency [43]. Klebsiella oxytoca has also been reported to be resistant to 
multiple antibiotics due to the chromosomal beta-lactamase over expression that leads to a characteristic 
antibiogram with high resistance to many available antibiotics [43, 44]. The acquisition of multidrug 
resistance (MDR) plasmids and chromosomal beta-lactamase over expression may be the reason for the low 
susceptibility and high resistivity reported in our study. This assertion is based on the obvious 
indiscriminate utilization of antibiotics by our population due to poverty and expensive delivery of health 
care services. The variations in antibiotics susceptibility potency between our study and previous studies, 
point toward the need for monitoring of antibiotic treatment and multiple antibiotic resistances. 
Conclusion 
Judging by the findings of this study, Klebsiella spp. possesses high antibiotic resistance to available 
antibiotics. The 100% resistance of Klebsiella spp. to some antibiotics in this study indicates serious 
problem with antibiotic treatments. In addition, the low sensitivity of many antibiotics observed in this 
study indicates Klebsiella organisms to be gaining renewed multidrug resistance among the available 
antibiotics. Thus, suggesting a threat to patients’ effective management, especially in developing countries 
where antibiotic susceptibility is not conducted routinely. It is therefore our recommendation that findings 
on antibiogram typing, antibiotic susceptibility and resistivity be communicated to clinicians and 
pharmacists for effective patient management. 
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